# id: 141633
# generation: 84
# extra edges: []
# score: 128.0 / 128.0
# following constraints: True
# complexity: 53

targets,	factors
AKT,	ERBB3 | PDK1 | mTOR
EGF,	EGF
ERBB1,	EGF & !erlotinib & !pertuzumab | PLCg & !erlotinib & !pertuzumab
ERBB2,	EGF & ERBB3 | EGF & !erlotinib & !pertuzumab & !trastuzumab | ERBB2 & !pertuzumab & !trastuzumab | ERBB3 & !trastuzumab
ERBB3,	HRG & !pertuzumab
ERK1_2,	EGF | ERK1_2 | MEK1_2 | pertuzumab
HRG,	HRG
MEK1_2,	ERBB1 & ERBB3 | ERBB2 | MEK1_2
PDK1,	ERBB1 & MEK1_2 | ERBB2 | ERBB3 & MEK1_2 | PDK1
PKCa,	PLCg | PKCa
PLCg,	EGF | ERBB1 & ERBB2 | PLCg
erlotinib,	erlotinib
mTOR,	AKT | mTOR | pertuzumab
p70S6K,	ERK1_2 | mTOR | p70S6K
pertuzumab,	pertuzumab
trastuzumab,	trastuzumab
